Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03604523 · ClinicalTrials.gov registry record · NA

Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation

A NA study, sponsored by University of Massachusetts, Worcester.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT03604523 is a NA study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03604523, a NA study, was terminated before completion, sponsored by University of Massachusetts, Worcester.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of the study is to prospectively evaluate the most effective treatment of esophageal dysmotility that alleviates symptoms of dysphagia and improves quality of life. Current practice uses either semi-rigid Savary dilators or balloon dilators for esophageal dilation to treat dysphagia due to esophageal dysmotility. The study aims to show which treatment method is more effective in alleviating symptoms, since there are no other treatments available. The null hypothesis is that there is no difference between the clinical benefits of each treatment.

Interventions

  • DEVICE Dilation by Balloon
  • DEVICE Dilation by Semi-rigid Savary

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-08-14
Est. Completion 2016-11-26
Phase NA

What the Registry Record Tells You About NCT03604523

The ClinicalTrials.gov registry entry for NCT03604523 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Dilation by Balloon is the first listed.

NCT03604523 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03604523 about?

NCT03604523 is a clinical study titled "Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation". The purpose of the study is to prospectively evaluate the most effective treatment of esophageal dysmotility that alleviates symptoms of dysphagia and improves quality of life. Current practice uses either semi-rigid Savary dilators or balloon dilators for esophageal dilation to treat dysphagia due...

What is the current status of trial NCT03604523?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2014-08-14. Estimated completion is 2016-11-26.

What interventions are being tested in trial NCT03604523?

The interventions under investigation include: Dilation by Balloon (DEVICE), Dilation by Semi-rigid Savary (DEVICE).

Who is sponsoring clinical trial NCT03604523?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.